Investment Information

With transparent disclosure of information and communication with markets,
we will grow along with shareholders.

News Room

News Room Search
News Room List
NO Title Date Viewers
29 HanAll Biopharma Announced 1H Results of Sales increased by 12.3% YoY · It Experienced the Turnaround with Operating Profit of KRW 1.9 billion 2018-08-14 3180
28 HanAll Biopharma’s New Antibody Drug, “HL161,” Accelerates its Global Development Through the Launch of Immunovant 2018-07-11 4644
27 HanAll Biopharma’s HL036 was Approved of its International Nonproprietary Name (INN) by the World Health Organization (WHO) 2018-06-25 3680
26 HanAll Biopharma and Daewoong Pharmaceutical Announced the Result of Phase 2 Clinical Trial of HL036 (a new drug for dry eye syndrome) in the U.S. 2018-05-29 3491
25 IM156, a new drug with original technology of HanAll Biopharma, is to be Introduced at the American Society of Clinical Oncology 2018-05-24 3030
24 Park Seung-kook, CEO of HanAll Biopharma Awarded of the President’s Citation on the Science Day 2018-04-23 2841
23 HanAll Biopharma Selected as Top 10 Science News of the Year 2018-01-04 1462
22 HanAll Biopharma Awarded the Prime Minister’s Citation at the Korea New Growth Management Awards 2017-12-21 1000
21 HanAll Biopharma has successfully transferred the technology of new antibody drug for autoimmune disease to a foreign company 2017-12-20 987
20 HanAll Biopharma and Harbour BioMed Sign Collaboration and License Agreement to Develop Two Novel Biologic Therapies in Greater China 2017-10-19 3508
1 2 3 현재 페이지4 5 6